Publisher
Springer Berlin Heidelberg
Reference16 articles.
1. Ahluwalia GS (2013) Safety and efficacy of bimatoprost solution 0,03% topical application in patientswith chemotherapy-induced eyelash loss. J Investig Dermatol Symp Proc 216:73–76
2. Altmeyer P, Bacharach-Buhles M, Leah Schröder-Bergmann L (2022) Altmeyers Enzyklopädie. Dermatologie. Springer. https://www.altmeyers.org/de/dermatologie. Zugegriffen am 03.01.2023
3. Belum VR, Marulanda K, Ensslin C, Gorcey L, Parikh T, Wu S et al (2015) Alopecia in patients treated with molecularly targeted anticancer therapies. Ann Oncol 12:2496–2502. https://doi.org/10.1093/annonc/mdv390
4. Common Terminology Criteria for Adverse Events (CTCAE), Deutsche Version 4.03, November 2017, National Institutes of Health, National Cancer Institute. CTCAE_4.03_deutsch_20190130_KLR.pdf (krebsregister-bw.de). Zugegriffen am Dezember 2022
5. Dai J, Belum VR, Wu S, Sibaud V, Lacouture ME (2017) Pigmentary changes in patients treated with targeted anticancer agents: a systematic review and meta-analysis. Am Acad Dermatol 77(5):902–910.e2. https://doi.org/10.1016/j.jaad.2017.06.044. PMID: 28918974; PMCID: PMC5657394